Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.03 USD
−101.06 M USD
755.00 K USD
69.26 M
About CELLECTIS
Sector
CEO
André Choulika
Headquarters
Paris
Website
Founded
1999
FIGI
BBG0084L1XN2
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.